Skip to the comparison

Independent review

Maximus review: GLP‑1 pricing and terms

4.4/5

Trustpilot, 1,096 reviews, read 19 Oct 2026

What you pay

$1,199.88 at this rate ÷ 12 months

$99.99/mo

billed as a term, not monthly

✓ Verified 5 Nov 2026

First year

$1,199.88–$2,399.88 longest to shortest plan, starting prices

Maximus's own site, not a paid placement

The price receipt

What makes up the total

Medication / month of the term
$99.99
Membership / month
$0
Term total, at this rate
$1,199.88

12-month plan, $1,199.88 at this rate

See the calculation

$1,199.88 ÷ 12 = $99.99/mo

Price verified ✓ Price checked

8.0/10 VerifiedDose score How we score this →

What Maximus charges, read from its own pages on 5 Nov 2026.

  • No membership fee

What each plan costs

  • TirzepatideCompounded · 12-month plan, $1,199.88 at this rate $99.99
  • TirzepatideCompounded · 6-month plan, $719.94 at this rate $119.99
  • TirzepatideCompounded · 4-month plan, $599.96 at this rate $149.99
  • TirzepatideCompounded · 2-month plan, $399.98 at this rate $199.99

Compounded medications are not FDA-approved: "Compounded drugs are not approved by FDA" (FDA, page current as of 1 Apr 2026, read 14 Oct 2026 (opens in a new tab)).

✓ Prices checked 5 Nov 2026

What stands out

  • Dose pricing Dose schedule not recorded
  • Insurance Insurance filing not recorded
  • Regulatory record FDA warning letter, Jun 2026
  • Legal entity Legal entity published
  • Price condition 12-month plan, $1,199.88 at this rate

At its lowest dated price, Maximus costs $99.99 a month (12-month plan, $1,199.88 at this rate), with no membership fee on top, checked 5 Nov 2026.

Maximus lists two compounded products and one branded plan that covers Ozempic, Mounjaro, Wegovy and Zepbound under a single starting figure. It carries an FDA warning letter, and our record holds no legal entity for the brand, so the only company name we have for it is the one on the regulator's letter.

Verdict: We would be slow to recommend Maximus. FDA issued a warning letter to Maximus Health, Inc. in June 2026 for false and misleading claims and misbranding. Its branded plan quotes one starting figure for four different drugs, so the price tells you almost nothing about what you would get. A good customer rating is a separate measurement.

  • Publishes a figure for every product it lists, so no row on this page had to be left as Not published.
  • Lists a branded route beside its compounded ones, so both sit on a single page and a change of product need not mean a change of provider.
  • Names the molecule on its cheapest compounded plan, so at least one row on the page tells you what it contains.

Quick facts

Medications
Mounjaro, Oral semaglutide, Orforglipron, Ozempic, Tirzepatide, Wegovy, Zepbound
Regulatory record
FDA letter, Jun 2026
Price history

How much does Maximus cost?

At its lowest dated price, Maximus costs $99.99 a month (12-month plan, $1,199.88 at this rate), with no membership fee on top, checked 5 Nov 2026.

Price changes appear in the change log.

Maximus plans. 10 plans, cash price per billing cycle with the date each price was verified.
Plan Medication Price What's included
Tirzepatide, 12-month plan, flat monthly rate Injection Compounded $99.99 12-month plan, $1,199.88 at this rate Price verified Price checked · 17 days ago Not stated by the provider
Tirzepatide, 6-month plan, flat monthly rate Injection Compounded $119.99 6-month plan, $719.94 at this rate Price verified Price checked · 17 days ago Same as above
Tirzepatide, 4-month plan, flat monthly rate Injection Compounded $149.99 4-month plan, $599.96 at this rate Price verified Price checked · 17 days ago Same as above
Orforglipron, Foundayo™ Tablets, starting at Oral $199.99 advertised Billing term not stated, so this is not comparable Figure read Same as above
Tirzepatide, 2-month plan, flat monthly rate Injection Compounded $199.99 2-month plan, $399.98 at this rate Price verified Price checked · 17 days ago Same as above
Oral semaglutide, Wegovy® Tablets, starting at Oral $249.99 advertised Billing term not stated, so this is not comparable Figure read Same as above
Wegovy, Wegovy® Pens, starting at Injection $349.99 advertised Billing term not stated, so this is not comparable Figure read Same as above
Ozempic, Ozempic®, starting at Injection $349.99 advertised Billing term not stated, so this is not comparable Figure read Same as above
Zepbound, Zepbound®, starting at Injection $449.99 advertised Billing term not stated, so this is not comparable Figure read Same as above
Mounjaro, Mounjaro®, starting at Injection $1,249.99 advertised Billing term not stated, so this is not comparable Figure read Same as above

How much is compounded tirzepatide at Maximus?

Compounded tirzepatide at Maximus starts at $99.99 a month (12-month plan, $1,199.88 at this rate), with no membership fee on top, checked 5 Nov 2026.

Where Maximus sits in our price rankings: 32nd of 38 in Cheapest GLP-1 telehealth · 25th of 34 in Best tirzepatide telehealth by price · 12th of 13 in Cheapest GLP-1 without membership. Each ranking groups providers by how they bill and whether we know their fee, then orders each group by what a year costs at the verified price.

What Wegovy costs across every channel we track is in our Wegovy price guide. What Zepbound costs across every channel we track is in our Zepbound price guide. What Orforglipron costs across every channel we track is in our Orforglipron price guide. What Oral semaglutide costs across every channel we track is in our Oral semaglutide price guide. What Tirzepatide costs across every channel we track is in our Tirzepatide price guide.

HSA/FSA accepted where the provider states it; we have not established whether insurance is billed.

Where it falls short

Maximus publishes three figures and very little else. Its branded plan is one starting price for Ozempic, Mounjaro, Wegovy and Zepbound together, which is the only listing of that shape we found anywhere in the providers we track, and it means the figure cannot tell you which drug it buys. Its dearest compounded plan names no molecule either. We could not establish a membership fee or whether it files insurance claims, and we hold no legal entity for the brand, so the only company name on this page is the one the FDA addressed its letter to.

  • FDA issued a warning letter to Maximus Health, Inc. dba Maximus in June 2026 for false and misleading claims and misbranding. Cited to the FDA's own record on this page.
  • One starting figure covers Ozempic, Mounjaro, Wegovy and Zepbound together, so the branded price does not tell you which drug it buys.
  • Our record holds no legal entity for the brand. The only company name we have for it is the one the FDA addressed its letter to.
  • We could not establish a membership fee, so the plan figure may not be everything you pay, and we could not establish whether it files insurance claims.

How Maximus compares

More columns to the right. Drag or swipe the table.

Maximus compared with 2 alternative providers.
Metric
VerifiedDose score 8.0 7.9 7.9
From $99.99 12-month plan, $1,199.88 at this rate Price verified Price checked · 17 days ago $149 Price verified ✓ Price checked $1,399 Price verified ✓ Price checked
Insurance Not recorded Files claimsNot recorded

How it works

Maximus terms: what the provider states about its model, timing, insurance and cancellation.

Model
Compounded
Membership fee
None ✓ checked 5 Nov 2026
Insurance
Not recorded
Time to prescription
Not stated
Cancellation
Not established
States served
Not recorded
Refunds
Not recorded
VerifiedDose score
8.0/10. How we rate providers.

Maximus reviews

Third-party aggregate, quoted not endorsed

4.4/5 on Trustpilot, from 1,096 reviews, read 19 Oct 2026

A lifetime average of reviews left on Trustpilot. It is not a measure of clinical care, and providers differ in when and how they ask for reviews.

See the profile on Trustpilot (opens in a new tab)

B BBB rating, not BBB accredited, read 19 Oct 2026

A BBB rating is BBB's own grade of the business, not an average of reviews.

See the profile on BBB (opens in a new tab)

Is Maximus legit? Its company and regulatory record

We don't certify companies; this is the record we hold for Maximus. Legal entity on file: Maximus Health, Inc. We hold 1 record on file for it, each with its source below; the latest is an FDA warning letter dated 8 Jun 2026.

We read its prices from its public pages; the latest reading is from 5 Nov 2026. Third-party reputation: Trustpilot 4.4 from 1,096 reviews, read 19 Oct 2026. Official domain: https://maximustribe.com/.

Regulatory record

1 regulatory record on file

What has changed

  • Price withdrawn

    Maximus $150 → not published

    Observation and source

    Seen on the provider's own page on 26 Oct 2026, recorded here on 26 Oct 2026.

    maximustribe.com/weight-loss/semaglutide now redirects to /weight-loss, and no compounded semaglutide is offered on any page read.

    The page this was read from (opens in a new tab)
  • Price withdrawn

    Maximus $79.99 → not published

    Observation and source

    Seen on the provider's own page on 26 Oct 2026, recorded here on 26 Oct 2026.

    maximustribe.com/weight-loss/semaglutide now redirects to /weight-loss, and no compounded semaglutide is offered on any page read.

    The page this was read from (opens in a new tab)
  • Price decreased

    Maximus $149.99 → $99.99

    Observation and source

    Seen on the provider's own page on 26 Oct 2026, recorded here on 26 Oct 2026.

    Tirzepatide 12-month plan, flat monthly rate — read from the provider's own page on 26 Oct 2026.

    The page this was read from (opens in a new tab)
  • Price decreased

    Maximus $199.99 → $119.99

    Observation and source

    Seen on the provider's own page on 26 Oct 2026, recorded here on 26 Oct 2026.

    Tirzepatide 6-month plan, flat monthly rate — read from the provider's own page on 26 Oct 2026.

    The page this was read from (opens in a new tab)
  • Price decreased

    Maximus $219.99 → $149.99

    Observation and source

    Seen on the provider's own page on 26 Oct 2026, recorded here on 26 Oct 2026.

    Tirzepatide 4-month plan, flat monthly rate — read from the provider's own page on 26 Oct 2026.

    The page this was read from (opens in a new tab)
  • Price decreased

    Maximus $249.99 → $199.99

    Observation and source

    Seen on the provider's own page on 26 Oct 2026, recorded here on 26 Oct 2026.

    Tirzepatide 2-month plan, flat monthly rate — read from the provider's own page on 26 Oct 2026.

    The page this was read from (opens in a new tab)
  • First price on record

    Maximus $150

    Observation and source

    Seen on the provider's own page on 13 Oct 2026, recorded here on 13 Oct 2026.

    Semaglutide GLP-1, starting at (how-it-works section, same page) — read from the provider's own page on 13 Oct 2026.

    The page this was read from (opens in a new tab)
  • Our record corrected

    Maximus $199.99 → not published

    Observation and source

    Seen on the provider's own page on 13 Oct 2026, recorded here on 13 Oct 2026.

    Correction to our record, not a change at Maximus: this summary row is replaced by one row per brand card, each priced on Maximus's page, the lowest being Foundayo at $199.99.

    The page this was read from (opens in a new tab)
  • First price on record

    Maximus $1249.99

    Observation and source

    Seen on the provider's own page on 13 Oct 2026, recorded here on 13 Oct 2026.

    Mounjaro Mounjaro®, starting at — read from the provider's own page on 13 Oct 2026.

    The page this was read from (opens in a new tab)
  • First price on record

    Maximus $449.99

    Observation and source

    Seen on the provider's own page on 13 Oct 2026, recorded here on 13 Oct 2026.

    Zepbound Zepbound®, starting at — read from the provider's own page on 13 Oct 2026.

    The page this was read from (opens in a new tab)

The record, and the company name on it

FDA addressed a letter to a named company in June 2026, and the subject line below is the agency's own. A warning letter is a regulator acting. It is not a court judgment and it is not a recall, and nothing here is our reading of what the company is like. One detail is worth pulling out. The letter names Maximus Health, Inc. as the company trading as Maximus, and our own research found no legal entity for this brand at all. The regulator's record is the only place we have a company name from.

FDA issued a warning letter to Maximus Health, Inc. dba Maximus for false and misleading claims and misbranding in connection with telehealth marketing.

FDA 8 Jun 2026 Primary source (opens in a new tab)

One figure, four different drugs

Maximus lists a branded plan and quotes a single starting figure for it. The products behind that figure are Ozempic, Mounjaro, Wegovy and Zepbound, named together on one row. Across every plan we track, this is the only listing that puts four named branded drugs behind one price. A comparison table reads that figure the same way it reads a figure attached to one product. The number is comparable and the thing it buys is not.

The compounded half of the list has a smaller version of the same problem. One of the two compounded plans is labelled by mechanism rather than by molecule, so what it contains is not on the page either. Both compounded figures are starting prices, and Maximus publishes no dose schedule behind them.

Two other things we could not establish. We found no membership fee for Maximus, so the plan figures may not be the whole monthly charge. We could not confirm whether it files insurance claims for you. In both cases the blank means we looked and did not find, not that the answer is no.

Questions readers ask

What does the Maximus branded plan get you?

The company does not say on the row we priced. One starting figure covers Ozempic, Mounjaro, Wegovy and Zepbound together, so the figure settles your budget and not your prescription.

Does Maximus charge a membership fee?

We could not establish it. The blank means we looked and did not find a figure, not that the fee is zero. The plan figure may not be everything you pay.

What company trades as Maximus?

We hold no legal entity for the brand. The FDA addressed its letter to Maximus Health, Inc. dba Maximus, and that letter is the only company name on this page.

Its customer rating is good. Why does the review still read this way?

The two measure different things. A rating collects what buyers said about their orders. The entry above is a regulator's action, with the agency's own record linked. We print both and leave them separate.

What does a higher dose cost at Maximus?

We cannot tell you. All three figures are starting prices and the company publishes no dose schedule, so there is nothing to read a higher figure from.

Where it prescribes

No state coverage on file for Maximus. Nothing published

Sources

How this site works

How we rate providers

Verified price, first-year cost, availability, speed to prescription, cancellation terms, regulatory record. Methodology.

No clinical review

We are not clinicians and this page carries no clinical review. Drug and regulatory facts are cited directly from FDA, CMS and court records.

How we make money

We may earn a referral fee from links on this page. Fees never influence ratings. Full disclosure.